Brief: Moberg Pharma: Sarah Hellerfelt To Leave Position As CFO
Oct 18 (Reuters) - Moberg Pharma AB (publ) MBPH.ST :
* CHANGES TO MOBERG PHARMA'S MANAGEMENT TEAM
* SARAH HELLERFELT HAS DECIDED TO LEAVE HER POSITION AS CFO
FOR
COMPANY
* MARK BEVERIDGE REASSUMES RESPONSIBILITY FOR FINANCE
FUNCTION AND
REPLACES SARAH HELLERFELT WHO HAS DECIDED TO LEAVE HER POSITION
AS CFO FOR COMPANY
Source text for Eikon: ID:nWkrTN4Tc
Further company coverage: MBPH.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587785110;))
Recent news on Moberg Pharma AB (publ)
See all newsSweden's Moberg Pharma Q2 loss narrows as revenue rises
Brief: Moberg Pharma Q2 EBITDA SEK -4.3 Million
Brief: Moberg Pharma Names Vaidrius Navikas Chief Medical Officer
Brief: Moberg Pharma And Karo Healthcare Expand Collaboration
Moberg Pharma Q1 revenue rises, losses narrow on Nordic market share gains